跳至主要内容
临床试验/NCT07226960
NCT07226960已完成不适用

Deprescribing in Outpatient Internal Medicine Practices

Wake Forest University Health Sciences2 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2025年11月12日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
26
试验地点
2
主要终点
Change in number of medications

研究概览

简要总结

The purpose of this study is to evaluate the impact of pharmacist-led medication reviews and deprescribing or de-escalation interventions on reducing the number of medications, falls, and hospitalizations, and improvement in quality of life in geriatric patients.

详细描述

With increasing age, key pharmacokinetic processes such as first-pass metabolism, bioavailability, drug distribution, and clearance, are affected, necessitating dose adjustments and careful medication management. Despite these risks, medication regimens in elderly patients are often left unchanged over time. Deprescribing, the intentional reduction or discontinuation of medications, has been shown to improve quality of life, reduce fall risk, minimize cognitive impairment, and decrease adverse drug interactions. In this analysis, the PharmD will perform a comprehensive medication review with the patient and collaborate with the provider and patient through shared decision making to deprescribe and/or dose reduce medication therapy where risks may outweigh benefits for the patient.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
75 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • 75 years or older
  • taking 6 or more medications

排除标准

  • patients in hospice or palliative care
  • in Skilled Nursing Facility
  • receiving cancer/oncology treatment

研究组 & 干预措施

medication review - deprescribing / de-escalation may occur

Experimental

Internal medicine providers and PharmDs will identify patients for whom a medication review and potential deprescribing / de-escalation intervention may be beneficial, and make recommendations to adjust therapy as appropriate.

干预措施: medication review (Behavioral)

historical controls

No Intervention

No contact or intervention will be made with these patients, only retrospective chart review to gather data such as number of medications, hospitalizations, and falls. Patients included in the historical control arm will be matched to the intervention group based on sex, age, and number of medications as much as possible. The goal will be to include 50 patients in both the intervention and control arms.

结局指标

主要结局

Change in number of medications

时间窗: Month 3

Change in number of medications

次要结局

  • Change in Medication Appropriateness Index scores(Month 3)
  • Change in Quality of life scores(Month 3)
  • Number of documented falls(Month 3)
  • Number of documented hospitalizations(Month 3)
  • Number of documented visits to Primary Care Physician office(Month 3)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验